UniDoc Health Corp (UDOC) AI Stock Analysis

• Market Cap: C$23.65M
• Dividend Yield: N/A
• Average Volume (3M): 25.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.12
• Revenue Growth: N/A
• EPS Growth: -50.06%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 77
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.13
• Shares Outstanding: 76,295,090
• 10 Day Avg. Volume: 16,669
• 30 Day Avg. Volume: 25,867
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• Price to Cash Flow (P/CF): -2.20
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

UniDoc Health Corp's overall score is low due to its poor financial performance and weak technical indicators. However, recent corporate events suggest potential for future improvements, although these efforts have yet to manifest in financial results.

UniDoc Health Corp Business Overview & Revenue Model

Company Description

UniDoc Health Corp (UDOC) is a healthcare technology company focused on providing innovative telemedicine solutions. It operates within the digital health sector, offering products and services that enable remote medical consultations and patient monitoring. The company's core offerings include telehealth platforms, virtual care solutions, and integrated health management systems designed to improve patient access to healthcare services and enhance the efficiency of healthcare providers.

How the Company Makes Money

UniDoc Health Corp generates revenue primarily through the sale and subscription of its telemedicine platforms and services to healthcare providers, clinics, and hospitals. Key revenue streams include subscription fees for access to its virtual care solutions, licensing fees for its telehealth technology, and service charges for maintaining and upgrading its systems. The company also forms strategic partnerships with healthcare organizations and technology firms to expand its market reach and enhance service offerings. Additionally, UniDoc may earn income from the implementation of customized solutions for large healthcare networks and through collaborative projects that contribute to technological advancements in telehealth.

UniDoc Health Corp Financial Statement Overview

Summary

UniDoc Health Corp faces significant financial challenges, with zero revenue leading to negative margins and consistent losses. The balance sheet shows financial instability with negative equity, and cash flows are unsustainable without strategic changes.

Income Statement

UniDoc Health Corp has consistently reported zero revenue, resulting in negative margins across the board. The lack of revenue growth and persistent net losses highlight significant challenges in achieving profitability. The company's negative gross profit and EBIT margins further emphasize the urgent need to generate sales to improve financial health.

Balance Sheet

The company's balance sheet indicates concerning financial instability, with stockholders' equity being negative in several periods. While the debt-to-equity ratio is relatively low due to minimal debt, negative equity and a low equity ratio suggest financial distress and potential solvency issues.

Cash Flow

UniDoc Health Corp's cash flow situation is precarious, with negative free cash flow and operating cash flow ratios indicative of continuous cash burn. The operating cash flow to net income ratio is poor, and the reliance on financing activities to cover cash deficits points to unsustainable operations without strategic changes.

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
0.00	0.00	0.00	0.00	0.00
	Gross Profit
-8.98K	-68.26K	-64.22K	-15.25K	0.00
	EBIT
-2.62M	-2.20M	-1.32M	-3.00M	-237.32K
	EBITDA
-5.83M	-2.18M	-1.26M	-2.99M	-237.32K
	Net Income Common Stockholders
-5.86M	-2.26M	-1.36M	-3.00M	-237.32K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.46M	398.88K	51.32K	854.43K	281.84K
	Total Assets
3.16M	517.08K	320.47K	1.18M	288.40K
	Total Debt
20.35K	74.86K	94.79K	79.29K	200.00K
	Net Debt
-2.44M	-324.03K	43.47K	-775.14K	-81.84K
	Total Liabilities
1.57M	2.38M	1.22M	721.60K	425.13K
	Stockholders Equity
1.59M	-1.86M	-900.79K	456.28K	-136.73K
Cash Flow		Free Cash Flow
-6.38M	-559.92K	-818.36K	-2.44M	17.25K
	Operating Cash Flow
-6.38M	-559.92K	-755.59K	-2.39M	17.25K
	Investing Cash Flow
-2.87K	0.00	-62.77K	-51.24K	0.00
	Financing Cash Flow
8.76M	907.48K	15.25K	3.01M	264.59K

UniDoc Health Corp Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.31
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:UDOC, the sentiment is Negative. The current price of 0.31 is below the 20-day moving average (MA) of 0.34, below the 50-day MA of 0.40, and below the 200-day MA of 0.50, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 40.64 is Neutral, neither overbought nor oversold. The STOCH value of 51.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:UDOC.

UniDoc Health Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WELL	77 Outperform	C$1.03B	13.42	9.25%	―	36.56%	―
Sector *	48 Neutral	$6.36B	1.14	-49.00%	2.63%	17.14%	1.39%
UDOC	34 Underperform	C$23.65M	―	-9999.00%	―	―	-50.06%

UniDoc Health Corp Corporate Events

UniDoc Health Corp Announces $500,000 Private Placement LIFE Offering

UniDoc Health Corp has announced a non-brokered private placement LIFE offering to raise up to $500,000 through the issuance of 2,000,000 units at $0.25 per unit. The proceeds will be used for inventory, marketing, investor relations, working capital, and general corporate purposes. The offering, expected to close by April 11, 2025, is subject to customary conditions and approvals, and aims to enhance the company’s operational capabilities and market presence.

UniDoc Health Corp Announces Debt Settlement and Marketing Renewal

UniDoc Health Corp has announced a debt settlement plan to issue approximately 266,400 common shares to settle $93,240 in debt owed to a creditor controlled by a company director. This move aims to preserve cash for working capital and improve financial positioning. Additionally, UniDoc has renewed its engagement with Rumble Strip Media Inc. for marketing and consulting services to enhance investor relations and maintain stock liquidity, reflecting the company’s strategy to support its capital-raising efforts.

UniDoc Health Corp Acquires AGNES Connect Software to Enhance eHealth Platform

UniDoc Health Corp has completed the acquisition of the AGNES Connect software from AMD Telemedicine, a move that integrates the software into UniDoc’s NEIL Connect platform. This acquisition is expected to bolster UniDoc’s market presence by expanding its customer base and generating sustainable revenue, as AGNES Connect has an established national and international network.

UniDoc Health Corp Acquires AGNES Connect to Boost eHealth Platform

UniDoc Health Corp has entered into a definitive purchase agreement to acquire the AGNES Connect software from AMD Telemedicine, a strategic move to enhance its NEIL Connect software platform. This acquisition will provide UniDoc with immediate access to AGNES Connect’s customer base, strengthen its AI-driven telehealth offerings, and improve operational efficiencies, positioning the company to deliver a more comprehensive eHealth solution and drive shareholder value.

UniDoc Health Corp Updates Interim Management Discussion for Clarity

UniDoc Health Corp has filed an amended and restated interim management’s discussion and analysis for the six-month period ending September 30, 2024, following a continuous disclosure review by the British Columbia Securities Commission. This amendment aims to clarify the company’s business nature, recent developments, contractual agreements, and advertising costs, potentially impacting the company’s transparency and stakeholder confidence.

UniDoc Health Corp Delivers AI-Equipped H3 Health Cubes to Key Regions

UniDoc Health Corp has successfully delivered its AI-assisted H3 Health Cubes to three commercial customers, marking the company’s shift into revenue generation. These deployments aim to improve healthcare accessibility in critical regions, with units sent to the Aiutamoli a Vivere Foundation in Italy, the Municipality of Aliano, and Ukraine’s Okhmatdyt Children’s Hospital. The H3 Health Cubes will assist in providing essential healthcare services in conflict-affected and rural areas, enhancing remote consultations and continuous health monitoring, ultimately addressing urgent healthcare needs.